CorMedix Announces Commercial Agreement With Top Tier Dialysis Provider For The Supply Of DefenCath
CorMedix Inc. (NASDAQ:CRMD), a biopharmaceutical company focused on developing therapeutic products for life-threatening diseases and conditions, today announced that it has entered into a multi-year commercial supply